G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital

NEXT STORY
Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF-100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress
PREV STORY
ERYTECH kündigt Posterpräsentationen auf der Jahrestagung der ASCO 2020 an
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with History of Inadequate Response

author_avatar
NASDAQ Market News

Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders

author_avatar
NASDAQ Market News

POC Diagnostics Market Size 2021 | Is Expected to Gain Momentum by Reaching USD 81.37 Billion by 2028 while Exhibiting a CAGR of 9.4%

author_avatar
NASDAQ Market News